ALB and cancer: By incorporating a fluorescent glycoprobe and an anti-cancer drug into HSA and assembling it with 2D MoS2, they created a 2D glycomaterial capable of selectively delivering therapeutic cargo to cancer cells expressing a Gal receptor.